Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARACHUTE Trial
2014-004849-26Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2015
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of antithymocyte globulin in leukemia, Immunodeficiency syndrome (IDS) and Disorders of Immunity (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: CD4+ T-cell immune reconstitution. Started Jan 2015; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
leukemiaImmunodeficiency syndrome (IDS)Disorders of Immunity
Beyond the preview
Go deeper on 2014-004849-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004849-26.